Manchester Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252 | Sell |
2
-1
| -33% | -$126 | ﹤0.01% | 1163 |
|
|
2025
Q1 | $332 | Hold |
3
| – | – | ﹤0.01% | 1103 |
|
|
2024
Q4 | $410 | Hold |
3
| – | – | ﹤0.01% | 1088 |
|
|
2024
Q3 | $346 | Hold |
3
| – | – | ﹤0.01% | 1104 |
|
|
2024
Q2 | $414 | Hold |
3
| – | – | ﹤0.01% | 1074 |
|
|
2024
Q1 | $414 | Buy |
+3
| New | +$414 | ﹤0.01% | 955 |
|
|
2023
Q4 | – | Sell |
-3
| Closed | -$338 | – | 1050 |
|
|
2023
Q3 | $338 | Buy |
+3
| New | +$338 | ﹤0.01% | 927 |
|
|
2021
Q1 | – | Sell |
-6
| Closed | -$1K | – | 731 |
|
|
2020
Q4 | $1K | Buy |
6
+3
| +100% | +$500 | ﹤0.01% | 667 |
|
|
2020
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 639 |
|